Cancer deaths down by 29 percent over last two decades

Cancer deaths down by 29 percent over last two decades

Prostate cancer is the most commonly diagnosed cancer in England Apart from prevention, it was shown that improved radon detection and mitigation has helped reduce lung cancer cases, since radon is the second most preventable cause of lung cancer, next to tobacco smoke. Further, early detection of lung cancer is important to initiate treatments promptly, improving the chances of fighting the disease. The earlier the treatment, the better the prognosis of cancer. Low-dose computed tomography (CT) screening has also played an imperative role in reducing lung cancer deaths. The test is recommended for high-risk patients who were current or former heavy smokers. In fact, detecting lung cancer early through CT has led to about a 20 percent decrease in death rates. The remainder of the decline can be attributed to advances in treatment. For over two decades, medicine has evolved and due to breakthroughs in discovering new drugs, including immunotherapy, more people were saved from cancer-related deaths. However, despite its declining numbers over the years, it is still the number one killer, with 228,820 new cases and 135,720 deaths predicted for the US in 2020 . WHO recommends steps to prevent cancer deaths The World Health Organization (WHO) highlights the importance of prevention and treatment of cancer cases , noting that stepping up cancer services in low and middle-income countries can save millions of lives. If current trends will continue, the WHO warns that the world will see a 60-percent increase in cancer diagnoses over the next 20 years. The greatest increase or 81 percent of the new cases will likely occur in low-and middle-income countries, where the survival rates are the lowest. “This is a wake-up call to all of us to tackle the unacceptable inequalities between cancer services in rich and poor countries. If people have access to primary care and referral systems then cancer can be detected early, treated effectively and cured. Cancer should not be a death sentence for anyone, anywhere,” Dr. Ren Minghui, Assistant Director-General, Universal Health Coverage/ Communicable and Noncommunicable Diseases, World Health Organization, said in a statement. With early detection and providing the current and modern interventions to patients, progress in poorer countries is achievable. “At least 7 million lives could be saved over the next decade, by identifying the most appropriate science for each country situation, by basing strong cancer responses on universal health coverage, and by mobilizing different stakeholders to work together”, Dr. Tedros Adhanom Ghebreyesus, Director-General, WHO, said. Sources: Siegel, R., Miller, K., and Jemal, A. (2020). Cancer statistics, 2020. American Cancer Society: A Cancer Journal for Clinicians. https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21590 World Health Organization (WHO). (2020). WHO outlines steps to save 7 million lives from cancer. https://www.who.int/news-room/detail/04-02-2020-who-outlines-steps-to-save-7-million-lives-from-cancer Journal reference: Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial List of authors. Harry J. de Koning, M.D., Ph.D., Carlijn M. van der Aalst, Ph.D., Pim A. de Jong, M.D., Ph.D., Ernst T. Scholten, M.D., Ph.D., Kristiaan Nackaerts, M.D., Ph.D., Marjolein A. Heuvelmans, M.D., Ph.D., Jan-Willem J. Lammers, M.D., Ph.D., Carla Weenink, M.D., Uraujh Yousaf-Khan, M.D., Ph.D., Nanda Horeweg, M.D., Ph.D., Susan van ’t Westeinde, M.D., Ph.D., Mathias Prokop, M.D., Ph.D., et al. https://www.nejm.org/doi/10.1056/NEJMoa1911793



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More